Brief: Kinnate Biopharma Reports Quarterly Loss Per Share Of $0.49
16/08/2021 22:06
Aug 16 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* KINNATE BIOPHARMA INC. REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS
* KINNATE BIOPHARMA INC QTRLY LOSS PER SHARE $0.49
* KINNATE BIOPHARMA INC - AS OF JUNE 30, 2021, TOTAL OF CASH
AND
CASH EQUIVALENTS AND INVESTMENTS WAS $365.1 MILLION
Source text for Eikon: ID:nGNX3LWh5S
Further company coverage: KNTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview